Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 129

1.

Nucleosome serum levels in acute hepatic failure and MARS treatment.

Roth GA, Lubsczyk BA, Pilz J, Faybik P, Hetz H, Krenn CG.

Transplant Proc. 2009 Dec;41(10):4207-10. doi: 10.1016/j.transproceed.2009.08.073.

PMID:
20005370
2.

MCP-1 and MIP3-alpha serum levels in acute liver failure and molecular adsorbent recirculating system (MARS) treatment: a pilot study.

Roth GA, Faybik P, Hetz H, Ankersmit HJ, Hoetzenecker K, Bacher A, Thalhammer T, Krenn CG.

Scand J Gastroenterol. 2009;44(6):745-51. doi: 10.1080/00365520902770086.

PMID:
19247846
3.

Lipocalin-2 serum levels are increased in acute hepatic failure.

Roth GA, Nickl S, Lebherz-Eichinger D, Schmidt EM, Ankersmit HJ, Faybik P, Hetz H, Krenn CG.

Transplant Proc. 2013 Jan-Feb;45(1):241-4. doi: 10.1016/j.transproceed.2012.02.047.

PMID:
23375308
4.

In vivo 1H magnetic resonance spectroscopy-derived metabolite variations between acute-on-chronic liver failure and acute liver failure.

Verma A, Saraswat VA, Radha Krishna Y, Nath K, Thomas MA, Gupta RK.

Liver Int. 2008 Sep;28(8):1095-103. doi: 10.1111/j.1478-3231.2007.01648.x. Epub 2008 Feb 8.

PMID:
18266634
5.

Molecular adsorbent recirculating system (MARS).

Tan HK.

Ann Acad Med Singapore. 2004 May;33(3):329-35. Review.

6.

Ratio of circulating follistatin and activin A reflects the severity of acute liver injury and prognosis in patients with acute liver failure.

Lin SD, Kawakami T, Ushio A, Sato A, Sato S, Iwai M, Endo R, Takikawa Y, Suzuki K.

J Gastroenterol Hepatol. 2006 Feb;21(2):374-80.

PMID:
16509861
7.

The effect of molecular adsorbent recirculating system treatment on survival, native liver recovery, and need for liver transplantation in acute liver failure patients.

Kantola T, Koivusalo AM, Höckerstedt K, Isoniemi H.

Transpl Int. 2008 Sep;21(9):857-66. doi: 10.1111/j.1432-2277.2008.00698.x. Epub 2008 May 29.

8.

[Clinical research of patients with acute or chronic hepatic failure treated with molecular adsorbent recirculating system].

Zhou X, Wang X, Yang Y, Zhao L, Miao J, Ding J, Fan D.

Zhonghua Gan Zang Bing Za Zhi. 2002 Jun;10(3):213-5. Chinese.

PMID:
12113683
9.

Liver transplantation reverses hypergammaglobulinemia in patients with chronic hepatic failure.

Lebherz-Eichinger D, Schwarzer R, Motal MC, Klaus DA, Mangold A, Ankersmit HJ, Berlakovich GA, Krenn CG, Roth GA.

Biochem Med (Zagreb). 2015 Jun 5;25(2):252-61. doi: 10.11613/BM.2015.026. eCollection 2015.

10.

Cost-effectiveness of the artificial liver support system MARS in patients with acute-on-chronic liver failure.

Hessel FP, Bramlage P, Wasem J, Mitzner SR.

Eur J Gastroenterol Hepatol. 2010 Feb;22(2):213-20. doi: 10.1097/MEG.0b013e3283314e48.

PMID:
19773666
11.

Pro-inflammatory interleukin-18 and Caspase-1 serum levels in liver failure are unaffected by MARS treatment.

Roth GA, Faybik P, Hetz H, Hacker S, Ankersmit HJ, Bacher A, Thalhammer T, Krenn CG.

Dig Liver Dis. 2009 Jun;41(6):417-23. doi: 10.1016/j.dld.2008.09.021. Epub 2008 Nov 18.

PMID:
19019743
12.

MARS therapy in critically ill patients with advanced malignancy: a clinical and technical report.

Tan HK, Lim JS, Tan CK, Ng HS, Chow P, Lui HF, Wong GC, Tan PH, Raghuram J, Ng HN, Choong LH, Wong KS, Woo KT.

Liver Int. 2003;23 Suppl 3:52-60.

PMID:
12950962
13.
14.

Comparison of long-term outcome of patients with Wilson's disease presenting with acute liver failure versus acute-on-chronic liver failure.

Thanapirom K, Treeprasertsuk S, Komolmit P, Tangkijvanich P, Kullavanijaya P.

J Med Assoc Thai. 2013 Feb;96(2):150-6.

PMID:
23936979
15.

Molecular adsorbent recirculating system for acute and acute-on-chronic liver failure: a meta-analysis.

Khuroo MS, Khuroo MS, Farahat KL.

Liver Transpl. 2004 Sep;10(9):1099-106. Review.

16.

Gc-globulin in liver disease.

Schiødt FV.

Dan Med Bull. 2008 Aug;55(3):131-46. Review.

PMID:
19232164
17.

The effect of albumin dialysis on cytokine levels in acute liver failure and need for liver transplantation.

Isoniemi H, Koivusalo AM, Repo H, Ilonen I, Höckerstedt K.

Transplant Proc. 2005 Mar;37(2):1088-90.

PMID:
15848631
18.

Is it possible to gain extra waiting time to liver transplantation in acute liver failure patients using albumin dialysis?

Koivusalo AM, Kantola T, Arola J, Höckerstedt K, Kairaluoma P, Isoniemi H.

Ther Apher Dial. 2009 Oct;13(5):413-8. doi: 10.1111/j.1744-9987.2009.00753.x. Erratum in: Ther Apher Dial. 2009 Dec;13(6):556.

PMID:
19788458
19.

[Evaluation of efficacy and safety of using molecular adsorbent recirculating system in the treatment of patients with chronic liver failure].

Lu XB, Xiao L, Zhang YX, Liu H, Yan GX, Xu L, Sun LH.

Zhongguo Wei Zhong Bing Ji Jiu Yi Xue. 2007 Jan;19(1):44-6. Chinese.

20.

Patients with acute on chronic liver failure display "sepsis-like" immune paralysis.

Wasmuth HE, Kunz D, Yagmur E, Timmer-Stranghöner A, Vidacek D, Siewert E, Bach J, Geier A, Purucker EA, Gressner AM, Matern S, Lammert F.

J Hepatol. 2005 Feb;42(2):195-201.

PMID:
15664244

Supplemental Content

Support Center